Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 6022

Imfinzi's latest label expansion; FDA seeks more information on BiomX's nebulizer

$
0
0
Plus, news about Ming Yu Pharmaceutical, Elpiscience Biopharmaceuticals, Chengdu Olymvax Biopharmaceuticals and Valneva: 🚦 AstraZeneca’s Imfinzi approved for perioperative use in stomach cancers: The PD-L1 inhibitor

Viewing all articles
Browse latest Browse all 6022

Trending Articles